미국의 가압 주입기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용량별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

U.S. Pressure Infusor Market Summary

The U.S. pressure infusor market size was estimated at USD 357.11 million in 2025 and is projected to reach USD 532.71 million by 2033, growing at a CAGR of 5.23% from 2026 to 2033. This growth is attributed to the increasing demand for rapid fluid resuscitation in emergency and critical care settings, rising adoption of disposable pressure infusors for infection control, and the growing number of surgical procedures requiring efficient fluid management.

The increasing volume of surgical procedures in the U.S. is a key driver for the pressure infusors industry. According to a study published by ScienceDirect in June 2024, the average total cardiac surgical volume in the U.S. reached 271.5 procedures per 100,000 population per year, reflecting the high procedural burden within hospital settings. Cardiac and other major surgeries often require rapid and controlled fluid or blood administration to maintain hemodynamic stability, particularly during intraoperative blood loss or postoperative complications. As surgical volumes continue to rise, hospitals and surgical centers are expected to increase procurement of essential perioperative devices, including pressure infusor bags, thereby supporting market growth in the U.S.

The growing burden of hemorrhagic conditions in the U.S. is contributing to increased demand for rapid fluid and blood administration devices. According to the American Heart Association, hemorrhagic strokes account for approximately 13% of all stroke cases, representing a significant subset of patients who may require urgent hemodynamic stabilization and blood product transfusion. Management of hemorrhagic stroke and other acute bleeding emergencies often involves rapid volume replacement to maintain cerebral perfusion and systemic stability. As the incidence of such critical bleeding events persists, hospitals and emergency departments continue to rely on pressure infusor bags for immediate and controlled transfusion support, thereby driving growth in the U.S. pressure infusor industry.

Ongoing product innovation and material advancements are further supporting the growth by improving safety, visibility, and clinical efficiency. Manufacturers are increasingly introducing latex-free materials to minimize allergy risks, along with clear or transparent pressure infusor bags that allow clinicians to visually monitor fluid levels, detect air bubbles, and quickly identify leaks without removing the IV bag. Reinforced seams enhance durability, while upgraded pressure gauges and controlled release valves provide more accurate and stable pressure delivery. Moreover, lightweight, high-strength polymer materials improve product longevity while maintaining cost-effectiveness. These innovations enhance usability in emergency and surgical settings, reduce operational risks, and encourage greater adoption across U.S. healthcare facilities.

U.S. Pressure Infusor Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. Pressure infusor market report based on product, capacity, application, and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Reusable pressure infusors
• Disposable pressure infusors
• Capacity Outlook (Revenue, USD Million, 2021 - 2033)
• 500 mL
• 1000 mL
• 3000 mL
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Emergency & Critical Care Resuscitation
• Blood and Blood Product Transfusion
• Surgical Fluid Management
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Infusion Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Capacity
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising demand for rapid fluid resuscitation in emergency, trauma, and critical care settings.
    • 3.2.1.2. Increasing number of surgical procedures
    • 3.2.1.3. Growing adoption of disposable pressure infusors
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Competition from alternative fluid delivery systems
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Pressure Infusor Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Reusable pressure infusors
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Disposable pressure infusors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pressure Infusor Market: Capacity Estimates & Trend Analysis

• 5.1. Capacity Mode Segment Dashboard
• 5.2. Capacity Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Capacity, 2021 to 2033 (USD Million)
• 5.4. 500 mL
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. 1000 mL
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. 3000 mL
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pressure Infusor Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Emergency & Critical Care Resuscitation
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Blood and Blood Product Transfusion
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Surgical Fluid Management
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Pressure Infusor Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Infusion Centers
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Market Position Analysis, 2025
• 8.2. Company Categorization
• 8.3. Company Profiles/Listing
  • 8.3.1. ICU Medical, Inc.
    • 8.3.1.1. Participant Overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Medline
    • 8.3.2.1. Participant Overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Merit Medical Systems.
    • 8.3.3.1. Participant Overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. ASP Global (acquired by Platinum Equity)
    • 8.3.4.1. Participant Overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Tapmedic LLC
    • 8.3.5.1. Participant Overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Spacelabs Healthcare
  • 8.3.7. AirLife
    • 8.3.7.1. Participant Overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. VBM Medical Inc.
    • 8.3.8.1. Participant Overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives